Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Press Releases
Immunic, Inc.  
January 7, 2025

Immunic Highlights 2024 Accomplishments and Upcoming Milestones

– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social